BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAK7 Class: NOTE 1.250% 5/1

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 546,000 Value ($000) $524 Avg Close — Range —
Q3 2025
Shares 500,000 Value ($000) $475 Avg Close — Range —
Q2 2025
Shares 300,000 Value ($000) $281 Avg Close — Range —
Q1 2025
Shares 300,000 Value ($000) $283 Avg Close — Range —
Q4 2024
Shares 300,000 Value ($000) $279 Avg Close — Range —
Q3 2024
Shares 300,000 Value ($000) $286 Avg Close — Range —
Q2 2024
Shares 300,000 Value ($000) $287 Avg Close — Range —
Q1 2024
Shares 300,000 Value ($000) $298 Avg Close — Range —
Q4 2023
Shares 300,000 Value ($000) $310 Avg Close — Range —
Q3 2023
Shares 200,000 Value ($000) $199 Avg Close — Range —
Q2 2023
Shares 200,000 Value ($000) $202 Avg Close — Range —
Q1 2023
Shares 300,000 Value ($000) $312 Avg Close — Range —
Q4 2022
Shares 300,000 Value ($000) $321 Avg Close — Range —
Q3 2022
Shares 300,000 Value ($000) $299 Avg Close — Range —
Q2 2022
Shares 300,000 Value ($000) $300 Avg Close — Range —
Q1 2022
Shares 500,000 Value ($000) $503 Avg Close — Range —
Q4 2021
Shares 500,000 Value ($000) $521 Avg Close — Range —
Q3 2021
Shares 500,000 Value ($000) $497 Avg Close — Range —
Q2 2021
Shares 500,000 Value ($000) $504 Avg Close — Range —